Mucosal and systemic HIV-1 Env-specific CD8+ T-cells develop after intragastric vaccination with a Salmonella Env DNA vaccine vector

Vaccine

Volumn 20, Issue 3-4, 2001, Pages 623-629

  Shata, Mohamed T ^a   Reitz Jr , Marvin S ^b   DeVico, Anthony L ^b   Lewis, George K ^b   Hone, David M ^b  

^a NEW YORK BLOOD CENTER   (United States)

^b INSTITUTE OF HUMAN VIROLOGY   (United States)

Author keywords

Human immunodeficiency virus; Mucosal immunity; Salmonella; Vaccine

Indexed keywords

CD8 ANTIGEN; DNA VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BACTERIAL MEMBRANE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; LYMPHOID TISSUE; MOUSE; MUCOSA; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SALMONELLA; T LYMPHOCYTE; VACCINATION; VIRUS ENVELOPE;

AIDS VACCINES; ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CODON; FEMALE; GENE PRODUCTS, ENV; GENETIC VECTORS; HIV-1; HUMANS; INTERFERON TYPE II; MICE; MICE, INBRED BALB C; SALMONELLA; VACCINATION; VACCINES, DNA;

EID: 0035851332     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(01)00330-9     Document Type: Article

References (37)

1. Protection against vaginal SIV transmission with microencapsulated vaccine
2. Protective mucosal immunity elicited by targeted iliac lymph node immunization with a subunit SIV envelope and core vaccine in macaques
3. Rhesus macaques previously infected with simian/human immunodeficiency virus are protected from vaginal challenge with pathogenic SIVmac239
4. HIV-specific mucosal and cellular immunity in HIV-seronegative partners of HIV-seropositive individuals
5. Mucosal immunization with HIV-1 peptide vaccine induces mucosal and systemic cytotoxic T lymphocytes and protective immunity in mice against intrarectal recombinant HIV-vaccinia challenge
6. Detection of major histocompatibility complex class I restricted, HIV-specific cytotoxic T lymphocytes in the blood of infected hemophiliacs
7. + cells varies among infected individuals
8. + cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection
9. + cell clones derived from HIV-infected and uninfected individuals
10. Strong cytotoxic T-cell and weak neutralizing antibody responses in a subset of persons with stable nonprogressing HIV type 1 infection
11. Induction of mucosal immunity by inactivated poliovirus vaccine is dependent on previous mucosal contact with live virus
12. Effective induction of HIV-specific CTL by multi-epitope using gene gun in a combined vaccination regime
13. Enhanced T-cell immunogenicity and protective efficacy of a human immunodeficiency virus type 1 vaccine regimen consisting of consecutive priming with DNA and boosting with recombinant fowlpox virus
14. Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations
15. Induction of mucosal and systemic responses against human immunodeficiency virus type 1 glycoprotein 120 in mice after oral immunization with a single dose of a Salmonella-HIV vector
16. Highly attenuated HIV type 2 recombinant poxviruses, but not HIV-2 recombinant Salmonella vaccines, induce long-lasting protection in rhesus macaques
17. Acute effects of pathogenic simian-human immunodeficiency virus challenge on vaccine-induced cellular and humoral immune responses to gag in rhesus macaques
18. Attenuated Shigella as a DNA delivery vehicle for DNA-mediated immunization
19. Oral somatic transgene vaccination using attenuated S. typhimurium
20. Gene transfer in dendritic cells, induced by oral DNA vaccination with Salmonella typhimurium, results in protective immunity against a murine fibrosarcoma
21. Mucosal DNA vaccine immunization against measles with a highly attenuated Shigella flexneri vector
22. An autologous oral DNA vaccine protects against murine melanoma
23. Molecular cloning and characterization of the HTLV-III virus associated with AIDS
24. Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines
25. Construction of genetically defined double aro mutants of Salmonella typhi
26. Codon usage limitation in the expression of HIV-1 envelope glycoprotein
27. Automated DNA sequencing: Ultrasensitive detection of fluorescent bands during electrophoresis
28. Direct gene transfer into mouse muscle in vivo
29. Helper T-cell subsets for immunoglobulin A responses: Oral immunization with tetanus toxoid and cholera toxin as adjuvant selectively induces Th2 cells in mucosa associated tissues
30. Mucosal adjuvant effect of cholera toxin in mice results from induction of T-helper 2 (Th2) cells and IL-4
31. An immunodominant epitope of the human immunodeficiency virus envelope glycoprotein gp160 recognized by class I major histocompatibility complex molecule-restricted murine cytotoxic T lymphocytes
32. Enumeration of IFN-γ-producing human lymphocytes by spot-ELISA. A method to detect lymphokine-producing lymphocytes at the single-cell level
33. + T-cells using an ELISPOT assay
34. Increased immune response elicited by DNA vaccination with a synthetic gp120 sequence with optimized codon usage
35. Construction and characterization of a Salmonella typhi-based human immunodeficiency virus type 1 vector vaccine
36. Pre-clinical development of a multi-CTL epitope-based DNA prime MVA boost vaccine for AIDS